These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6932053)

  • 41. Guanabenz acetate: a new, long-acting alpha-two adrenergic agonist for opioid withdrawal.
    Tennant FS; Rawson RA
    NIDA Res Monogr; 1984 Mar; 49():338-43. PubMed ID: 6090917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone.
    Charney DS; Heninger GR; Kleber HD
    Am J Psychiatry; 1986 Jul; 143(7):831-7. PubMed ID: 3717421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.
    Gold MS; Redmond DE; Kleber HD
    Am J Psychiatry; 1979 Jan; 136(1):100-2. PubMed ID: 364997
    [No Abstract]   [Full Text] [Related]  

  • 45. Reduction of opiate withdrawal symptoms with use of clonidine in a county jail.
    Fresquez-Chavez KR; Fogger S
    J Correct Health Care; 2015 Jan; 21(1):27-34. PubMed ID: 25431436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts.
    Camí J; Gilabert M; San L; de la Torre R
    Br J Addict; 1992 Aug; 87(8):1145-51. PubMed ID: 1511228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms.
    Charney DS; Sternberg DE; Kleber HD; Heninger GR; Redmond DE
    Arch Gen Psychiatry; 1981 Nov; 38(11):1273-7. PubMed ID: 7305608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clonidine in opiate withdrawal.
    Johnson MM
    J Natl Med Assoc; 1983 Feb; 75(2):131. PubMed ID: 6827605
    [No Abstract]   [Full Text] [Related]  

  • 49. The clinical use of clonidine in outpatient detoxification from opiates.
    Washton AM; Resnick RB
    Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
    [No Abstract]   [Full Text] [Related]  

  • 50. Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.
    Rawson RA; Washton AM; Resnick RB; Tennant FS
    Adv Alcohol Subst Abuse; 1984; 3(3):41-9. PubMed ID: 6093484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Convincing effects of clonidine on neurohumoral withdrawal symptoms during antagonist-supported detoxification of opioid addicts.
    White PF; Wender RH
    Anesth Analg; 2003 Nov; 97(5):1548. PubMed ID: 14570693
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns.
    Kienbaum P; Scherbaum N; Thürauf N; Michel MC; Gastpar M; Peters J
    Crit Care Med; 2000 Apr; 28(4):969-76. PubMed ID: 10809268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonidine and opiate withdrawal.
    Gold MS; Pottash AL; Extein I; Kleber HD
    Lancet; 1980 Nov; 2(8203):1078-9. PubMed ID: 6107698
    [No Abstract]   [Full Text] [Related]  

  • 54. Clonidine treatment of neonatal narcotic abstinence syndrome.
    Hoder EL; Leckman JF; Poulsen J; Caruso KA; Ehrenkranz RA; Kleber HD; Cohen DJ
    Psychiatry Res; 1984 Nov; 13(3):243-51. PubMed ID: 6597462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Case of Delirium and Rhabdomyolysis in Severe Iatrogenic Opioid Withdrawal.
    Hanna J; Swetter S
    Psychosomatics; 2018; 59(4):405-407. PubMed ID: 29325983
    [No Abstract]   [Full Text] [Related]  

  • 56. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial.
    Ahmadi-Abhari SA; Akhondzadeh S; Assadi SM; Shabestari OL; Farzanehgan ZM; Kamlipour A
    J Clin Pharm Ther; 2001 Feb; 26(1):67-71. PubMed ID: 11286609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal.
    Akhondzadeh S; Ahmadi-Abhari SA; Assadi SM; Shabestari OL; Kashani AR; Farzanehgan ZM
    J Clin Pharm Ther; 2000 Oct; 25(5):347-53. PubMed ID: 11123486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Detoxification in withdrawal state in methadone maintenance patients].
    Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of clonidine in opiate withdrawal: a study of thirty patients.
    Gold MS; Pottash AL; Sweeney DR; Kleber HD
    Drug Alcohol Depend; 1980 Oct; 6(4):201-8. PubMed ID: 7023893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.